-
New Phase 3 Trial Launches for Oral VK2735 in Weight Management for Adults with Type 2 Diabetes
A new Phase 3 study, SUNRISE 2, is underway to evaluate oral VK2735 as a weight management option for adults with Type 2 Diabetes who are overweight or obese. The trial marks continued progress toward expanding treatment options for this patient population.
-
New Clinical Trial Explores Peptide Hormones to Protect Heart Health in People with HIV
The ENCHANTMENT HIV study is investigating whether therapies targeting aldosterone and BNP, two hormones linked to heart health, could help reduce cardiovascular risk in people living with HIV.
-
New Clinical Trial Explores Blood Biomarkers to Protect the Heart During Lung Cancer Radiation Therapy
A new study is examining whether two blood-based biomarkers, including the peptide NT-proBNP, can help doctors predict and prevent heart complications in lung cancer patients undergoing radiation treatment.
-
FDA-Approved Peptide Therapies Continue to Expand Options for Weight Management
Peptide-based medications continue to gain regulatory traction as effective tools for weight management, offering patients more science-backed options under medical supervision.
-
FDA-Approved Peptide Therapies Continue to Expand Options for Weight Management
The FDA has approved several peptide-based medications for chronic weight management, offering new options for individuals working with healthcare providers to address obesity.
-
New Clinical Framework Supports Safely Reducing Insulin Use with GLP-1 Therapy in Type 2 Diabetes
A newly published clinical framework in Cureus outlines evidence-based strategies for safely reducing insulin doses in type 2 diabetes patients who are also using GLP-1-based therapies. The approach offers clinicians a practical roadmap for simplifying treatment regimens while maintaining blood sugar control.
-
New Comparative Trial Explores Metformin and Insulin Options for Gestational Diabetes Care
A large U.S. multi-site study will compare oral metformin to injectable insulin for gestational diabetes, aiming to give pregnant individuals more evidence-based treatment choices.
-
New Clinical Trial Explores Advanced PET Imaging to Better Detect Lung Sarcoidosis
Researchers are investigating whether several established PET imaging tracers can help identify active granulomas in pulmonary sarcoidosis, potentially improving diagnosis and monitoring of the disease.
-
New Clinical Trial Explores Combination Therapy for Hard-to-Treat Lung and Neuroendocrine Cancers
A phase II trial is investigating whether pairing niraparib, a PARP inhibitor, with the immunotherapy dostarlimab can help control small cell lung cancer and other high-grade neuroendocrine carcinomas.
-
FDA Advisory Committee Expresses Support for Popular Wellness Peptides
An FDA advisory committee has voted in favor of several widely-used wellness peptides, signaling a potentially positive step forward for their regulatory standing. The committee’s support comes even as agency staff raised some points for further consideration.